Introduction
The widespread interest in developing structureactivity correlations for opioid peptides [I-31 has led to a large number of investigations on the preferred solution conformations of enkephalins [4-1 I]. The results of these studies have led to proposals ranging from p-turn conformations. With Gly2-Gly3 [I41 or Gly3-Phe4 [4-101 as the corner residues. Evidence for the lack of preferred conformations in solutions, resulting from dynamic averaging between an ensemhle of structures, has also been presented [ l l ] . While a consensus has yet t o be reached on the solution conformations of enkephalins, there is general agreement that receptor interactions presumably involve a folded, defined conformation of the pentapeptide [ 12-14]. The recognition of multiple receptor sites foi opioid ligands [15-171, has provided a further impetus for studies of conformational flexibility in enkephalins, with the possibility that interaction a t p and 6 sites may be mediated through different conformations of the peptides [I 81. Here, we describe an unusual solvent-dependent conformational transition, in the protected fragment Boc-GlyGly-Phe-Met-NH, and Met'-enkephalinamide which is abolished on restricting conformational freedom by substitution of Gly by a-aminoisobutyryl (Aib) residues [19, 20] . 
Results and discussion
Fig1 shows the CD spectrum of Roc-Gly-GlyPhe-Met-NH2 ( I ) in methanol, trifluoroethanol (TFE) and a 1 : 1 (v/v) mixture of these solvents. In MeOH, a weak negative band at 235 nm and a strong positive band a t 218 nm is observed, whereas in TFE -there is a dramatic change, with only a negative band at 228 nm. This suggests that the peptide undergoes a large conformational change on going from MeOII to TFE. Interestingly, the spectrum in a 1 :1 solvent mixture ( fig.lc) , exhibits CD bands characteristic of both solvents, suggesting that different conformational states may be populated. A similar solvent dependent reversal of the signs of the CD bands is also observed in Met'~nkeph~inarnide (Tyr-GlyGly-Plie-Met-NH2) and Boc-Tyr-Gly-Gly-PheLeu-NH2 ( fig.2 ). Aib residues, in which both CIy hydrogens of Gly are replaced by methyl groups, can be used to restrict the conformational flexibility of small acyclic peptides [21--25] lead us to conclude that in 2, @turn structures having Aib-Gly as the corner residues are significantiy populated. This conformation is stabilized by a 4 + 1 hydrogen bond between the Boc CO-and Phe NH-groups ( fig.4a ). In peptides 3 and 4 the NMR data favours incipient 310 helical structures formed by consecutive type 111 &turns having X-Aib and fib-Phe as the corner residues ( X = Aib in 3 and Gly in 4). These conformations require that both Phe and Met NII groups are intramoiecu~rly hydrogenbonded (figAb). Such structures have been unambig ppm/'C) 
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Phe-Leu-NH, TFE ( uously established in solution and solid state for Aib containing oligopeptides [21-251. The CD data presented above show that peptides with the Gly-Gly sequence exhibit similarities to the Aib analogs 2 or 4, depending on the solvent conditions. It thus appears that both Gly2-Gly3 and Gly3-Phe4 0-turn conformations for enkephalins may be energetically close, leading to large solvent-dependent changes in conformer populations. This may account for the apparently conflicting proposals put forward in the literature. Theoretical studies have favoured Gly2-Gly3 p-turn structures [14, 27] and a type I' Gly2-Gly3 &turn has been observed in the solid state [28] . Spectroscopic 
